Abstract
Complement deficient patients are susceptible to rare meningococcal serogroups. A 6-year-old girl presented with serogroup Z meningitis. This led to identification of a C8 deficiency. The MenB-4C vaccine induced cross-reactive antibodies to serogroup Z and increased in vitro opsonophagocytic killing and may thus protect complement deficient patients.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
MeSH terms
-
Antibodies, Bacterial / immunology
-
Child
-
Complement C8 / deficiency*
-
Cross Protection / immunology*
-
Cross Reactions / immunology
-
Female
-
Hereditary Complement Deficiency Diseases
-
Humans
-
Meningitis / diagnosis
-
Meningitis / immunology
-
Meningitis / microbiology*
-
Meningococcal Infections / prevention & control
-
Meningococcal Vaccines / administration & dosage
-
Meningococcal Vaccines / immunology*
-
Neisseria meningitidis / classification
-
Neisseria meningitidis / immunology*
-
Opsonization
-
Serogroup*
Substances
-
Antibodies, Bacterial
-
Complement C8
-
Meningococcal Vaccines